A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Exclusion Criteria

• •Co-existing Condition:
• •Patients with the following symptoms or conditions are excluded:
• •Symptomatic neuropathy.
• •Acute hepatitis.
• •Concurrent Medication:
• •Excluded:
• •Antiretrovirals other than specified in protocol.
• •Chronic therapy for an active opportunistic infection.
• •Immunosuppressive therapy.
• •Prior Medication:
• •Excluded:
• •Any prior protease inhibitor or d4T.
• •Any nucleoside analogs within 2 weeks prior to study entry.
• •Investigational agents or immunomodulators within 30 days prior to study entry.
• •Required:
• •More than 6 months of prior AZT unless intolerant, in which case more than 6 months of another anti-HIV therapy (other than protease inhibitors or d4T).